Literature DB >> 12183587

Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.

Irving Nachamkin1, Jirong Liu, Ming Li, Huong Ung, Anthony P Moran, Martina M Prendergast, Kazim Sheikh.   

Abstract

GM(1)- and GD(1a)-like ganglioside mimicry in Campylobacter jejuni lipooligosaccharide (LOS) is considered to be involved in the pathogenesis of Campylobacter-induced Guillain-Barré syndrome (GBS). Compared with gastroenteritis-related isolates, GBS-related C. jejuni isolates were strongly associated with the expression of GD(1a)-like mimicry. The presence of a few genes involved in LOS ganglioside mimicry, cst-II, cgtA, and cgtB, was also associated with GBS-related strains. GD(1a)-like epitope expression may be an important virulence phenotype associated with the risk of developing GBS following campylobacter infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183587      PMCID: PMC128258          DOI: 10.1128/IAI.70.9.5299-5303.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.

Authors:  H P Endtz; C W Ang; N van Den Braak; B Duim; A Rigter; L J Price; D L Woodward; F G Rodgers; W M Johnson; J A Wagenaar; B C Jacobs; H A Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.

Authors:  M P Lunn; L A Johnson; S E Fromholt; S Itonori; J Huang; A A Vyas; J E Hildreth; J W Griffin; R L Schnaar; K A Sheikh
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

3.  HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection.

Authors:  J H Rees; R W Vaughan; E Kondeatis; R A Hughes
Journal:  J Neuroimmunol       Date:  1995-10       Impact factor: 3.478

4.  Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.

Authors:  I Nachamkin; H Ung; A P Moran; D Yoo; M M Prendergast; M A Nicholson; K Sheikh; T Ho; A K Asbury; G M McKhann; J W Griffin
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome.

Authors:  M Nishimura; M Nukina; S Kuroki; H Obayashi; M Ohta; J J Ma; T Saida; T Uchiyama
Journal:  J Neurol Sci       Date:  1997-12-09       Impact factor: 3.181

6.  Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy.

Authors:  S Kusunoki; S Hitoshi; K Kaida; M Arita; I Kanazawa
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

7.  Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility.

Authors:  K A Sheikh; I Nachamkin; T W Ho; H J Willison; J Veitch; H Ung; M Nicholson; C Y Li; H S Wu; B Q Shen; D R Cornblath; A K Asbury; G M McKhann; J W Griffin
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

8.  Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.

Authors:  T W Ho; H J Willison; I Nachamkin; C Y Li; J Veitch; H Ung; G R Wang; R C Liu; D R Cornblath; A K Asbury; J W Griffin; G M McKhann
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

9.  Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin.

Authors:  D A Sack; A J Lastovica; S H Chang; G Pazzaglia
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  Anti-GD1a ganglioside antibodies in peripheral motor syndromes.

Authors:  M Carpo; E Nobile-Orazio; N Meucci; M Gamba; S Barbieri; S Allaria; G Scarlato
Journal:  Ann Neurol       Date:  1996-04       Impact factor: 10.422

View more
  38 in total

Review 1.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

2.  Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.

Authors:  Frédéric Poly; Timothy D Read; Yu-Han Chen; Mario A Monteiro; Oralak Serichantalergs; Piyarat Pootong; Ladaporn Bodhidatta; Carl J Mason; David Rockabrand; Shahida Baqar; Chad K Porter; David Tribble; Michael Darsley; Patricia Guerry
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

Review 3.  Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections.

Authors:  Adrienne W Paton; Renato Morona; James C Paton
Journal:  Bioeng Bugs       Date:  2009-11-17

4.  Crystal structure of JlpA, a surface-exposed lipoprotein adhesin of Campylobacter jejuni.

Authors:  Fumihiro Kawai; Seonghee Paek; Kyoung-Jae Choi; Michael Prouty; Margaret I Kanipes; Patricia Guerry; Hye-Jeong Yeo
Journal:  J Struct Biol       Date:  2012-01-08       Impact factor: 2.867

Review 5.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

6.  Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate.

Authors:  Maojun Zhang; Lihua He; Qun Li; Honghe Sun; Yixin Gu; Yuanhai You; Fanliang Meng; Jianzhong Zhang
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 7.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

8.  MLST clustering of Campylobacter jejuni isolates from patients with gastroenteritis, reactive arthritis and Guillain-Barré syndrome.

Authors:  L N Nielsen; S K Sheppard; N D McCarthy; M C J Maiden; H Ingmer; K A Krogfelt
Journal:  J Appl Microbiol       Date:  2009-06-25       Impact factor: 3.772

9.  AI-2 does not function as a quorum sensing molecule in Campylobacter jejuni during exponential growth in vitro.

Authors:  Kathryn Holmes; Tim J Tavender; Klaus Winzer; Jerry M Wells; Kim R Hardie
Journal:  BMC Microbiol       Date:  2009-10-08       Impact factor: 3.605

10.  Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Jaap A Wagenaar; Alison J Cody; Albert G de Boer; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.